Testing effectiveness (Phase 2)Active Not RecruitingNCT06293365
What this trial is testing
Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease
Who this might be right for
Sjögrens DiseaseSystemic Lupus ErythematosusRheumatoid Arthritis
Novartis Pharmaceuticals 155